Briefing: How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real.
Briefing: Vaccinating bats could be good for people. But how do you vaccinate a bat?
Strategic angle: In a new study, bats lap up vaccine-laced saline or chow down on vaccine-carrying mosquitoes. Will that have any impact on the flying mammal's immune system?
Briefing: Bacterial strain breaks decades-old bottleneck in chemotherapy drug manufacturing
Strategic angle: An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent.
Briefing: As 800,000 flee, half of Lebanon lives in war zones without markets, supplies or healthcare
Strategic angle: Genie Godula welcomes Hassan Al-Sayed from Solidarités International, discussing the humanitarian crisis in Lebanon.
Briefing: Ulta Beauty Price Prediction: Post-Earnings Selloff Creates Entry Opportunity
Strategic angle: Analysts suggest that the recent selloff in Ulta Beauty's stock presents a potential buying opportunity for investors.
Briefing: Who is Pakistan supporting in Iran war?
Strategic angle: Islamabad has so far presented itself as a 'neutral' party in the conflict, condemning the US-Israeli strikes on Iran as well as castigating Tehran for its attacks on Saudi Arabia and other Gulf countries.
Briefing: Trump's Influence on Drug Prices: A Closer Look
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
Briefing: Who are the key figures in the sewage crisis, and where are they now?
Strategic angle: With anger stoked by Channel 4’s drama Dirty Business, we look at what has happened to some of the main players.
Briefing: Make next year’s flu shots, says FDA committee
Strategic angle: Vaccine skepticism, FDA-authorized vape flavors, and more health news from Morning Rounds
Poll: Public Worries About Prescription Drug Costs Reach New High
Most Across Political Parties Want Government to Do More to Regulate Prices
Briefing: Trump is getting more credit than Biden for efforts to lower drug prices
Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx.
Briefing: FDA move on flavored vapes rattles public health experts
Strategic angle: New FDA guidance suggests mint, coffee, and spice vape flavors could be authorized, raising debate over toxic additives and youth vaping risks.
Briefing: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality
Strategic angle: The legal battle underscores the complicated questions surrounding how best to evaluate hospital safety.
Briefing: Gunman who injured 2 people at Old Dominion University in Virginia is dead, college says
Strategic angle: Incident at Old Dominion University leads to the death of the gunman.
Briefing: The Impact of Gun Violence on Youth Mental Health and Well-Being
Strategic angle: Exposure to gun violence can severely affect the mental health of children and adolescents.
Briefing: Child and Adolescent Firearm Deaths: National Trends and Variation by Demographics and States
Strategic angle: This brief analyzes the latest youth mortality data from the CDC, revealing alarming trends in firearm-related deaths among children and adolescents.
Briefing: Analysis of Medicare data shows who mental health providers treat over telehealth
Strategic angle: A new analysis reveals that mental health specialists utilizing telehealth did not significantly increase their rural patient base.
Briefing: An NIH Whistleblower Warning
Strategic angle: The doctors behind the telehealth GLP-1 boom, a men's health office moment, and other health news
Briefing: Fortified salad packs a healthy punch to meet a growing vitamin B12 need
Strategic angle: A pioneering research-industry partnership has utilized indoor farming technology to grow vitamin B12 fortified pea shoots, addressing a significant public health need.
Briefing: Failed experiment leads to surprise drug development breakthrough
Strategic angle: Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals.